دورية أكاديمية
A20 in Kidney Transplantation and Autoimmunity.
| العنوان: | A20 in Kidney Transplantation and Autoimmunity. |
|---|---|
| المؤلفون: | Kommer A; Department of Nephrology, I. Department of Medicine, University Medical Center Mainz, Johannes Gutenberg University, D 55131 Mainz, Germany., Meineck M; Department of Nephrology, I. Department of Medicine, University Medical Center Mainz, Johannes Gutenberg University, D 55131 Mainz, Germany., Classen P; Department of Nephrology, I. Department of Medicine, University Medical Center Mainz, Johannes Gutenberg University, D 55131 Mainz, Germany., Weinmann-Menke J; Department of Nephrology, I. Department of Medicine, University Medical Center Mainz, Johannes Gutenberg University, D 55131 Mainz, Germany. |
| المصدر: | International journal of molecular sciences [Int J Mol Sci] 2024 Jun 16; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 16. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI, [2000- |
| مواضيع طبية MeSH: | Kidney Transplantation* , Autoimmunity* , Tumor Necrosis Factor alpha-Induced Protein 3*/metabolism , Tumor Necrosis Factor alpha-Induced Protein 3*/genetics, Humans ; Animals ; Autoimmune Diseases/immunology ; Autoimmune Diseases/therapy ; Graft Rejection/immunology ; Graft Rejection/prevention & control |
| مستخلص: | A20, the central inhibitor of NFκB, has multiple anti-inflammatory properties, making it an interesting target in kidney autoimmune disease and transplant biology. It has been shown to be able to inhibit inflammatory functions in macrophages, dendritic cells, T cells, and B cells in various ways, leading to less tissue damage and better graft outcomes. In this review, we will discuss the current literature regarding A20 in kidney transplantation and autoimmunity. Future investigations on animal models and in existing immunosuppressive therapies are needed to establish A20 as a therapeutic target in kidney transplantation and autoimmunity. Cell-based therapies, modified viruses or RNA-based therapies could provide a way for A20 to be utilized as a promising mediator of inflammation and tissue damage. |
| References: | Ann N Y Acad Sci. 2005 Nov;1056:218-33. (PMID: 16387690) J Clin Immunol. 2024 Mar 7;44(3):76. (PMID: 38451381) Transplantation. 2002 Apr 15;73(7):1079-85. (PMID: 11965035) Am J Transplant. 2011 Oct;11(10):2093-109. (PMID: 21883901) Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. (PMID: 20599425) J Immunol. 2000 Jul 15;165(2):1013-21. (PMID: 10878378) Biochem Biophys Res Commun. 2012 Feb 10;418(2):433-8. (PMID: 22285182) J Am Soc Nephrol. 2005 Jun;16(6):1542-8. (PMID: 15888558) Transplantation. 2012 Feb 27;93(4):373-82. (PMID: 22245872) Transplant Direct. 2015 Jul 28;1(6):e23. (PMID: 27500225) Int J Immunogenet. 2016 Apr;43(2):96-100. (PMID: 26846592) Transplant Proc. 2006 Dec;38(10):3225-7. (PMID: 17175229) Front Pharmacol. 2022 May 03;13:845262. (PMID: 35592427) Ann Rheum Dis. 2019 Oct;78(10):1363-1370. (PMID: 31300459) Cancer Lett. 2021 Jul 28;511:26-35. (PMID: 33933552) Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. (PMID: 35529086) Microbes Infect. 2011 Mar;13(3):209-15. (PMID: 21111841) Int Immunopharmacol. 2021 Aug;97:107804. (PMID: 34062371) Clin Exp Nephrol. 2020 Feb;24(2):107-118. (PMID: 31811410) Kidney Int. 2019 Jan;95(1):50-56. (PMID: 30606429) Nat Immunol. 2020 Apr;21(4):422-433. (PMID: 32205880) Dig Liver Dis. 2019 Jun;51(6):790-797. (PMID: 30528569) J Immunol. 2009 Jul 15;183(2):1488-95. (PMID: 19553520) Rinsho Ketsueki. 2011 Apr;52(4):190-7. (PMID: 21566404) Lancet. 2004 Nov 13-19;364(9447):1814-27. (PMID: 15541456) Trends Immunol. 2023 Aug;44(8):628-643. (PMID: 37357102) PLoS One. 2010 Dec 06;5(12):e14240. (PMID: 21151899) Mol Cell Biol. 2007 Nov;27(21):7451-61. (PMID: 17709380) Mol Cell. 2010 Nov 24;40(4):548-57. (PMID: 21095585) Arthritis Rheum. 2010 Aug;62(8):2313-21. (PMID: 20506221) Genes Immun. 2009 Jul;10(5):470-7. (PMID: 19387456) J Biol Chem. 2014 Nov 7;289(45):30912-24. (PMID: 25217635) Autophagy. 2015;11(7):1052-62. (PMID: 26043155) Asian Pac J Allergy Immunol. 2020 Dec;38(4):225-232. (PMID: 31837212) Blood. 2011 Feb 17;117(7):2227-36. (PMID: 21088135) PLoS One. 2019 Sep 23;14(9):e0222697. (PMID: 31545817) Ann Rheum Dis. 2010 Nov;69(11):1958-64. (PMID: 20511617) Cell Immunol. 2021 Jul;365:104375. (PMID: 33975174) Kidney Int. 2004 Aug;66(2):523-7. (PMID: 15253702) Front Cardiovasc Med. 2021 May 07;8:651230. (PMID: 34026871) Int J Mol Med. 2016 Jul;38(1):161-71. (PMID: 27177159) Hum Immunol. 2010 May;71(5):451-5. (PMID: 20156509) Cancer Discov. 2012 Feb;2(2):140-55. (PMID: 22585859) Clin Kidney J. 2022 Jun 09;15(11):1973-1980. (PMID: 36324999) J Biol Chem. 1990 Feb 15;265(5):2973-8. (PMID: 2406243) J Mol Med (Berl). 2008 Dec;86(12):1329-39. (PMID: 18813897) Nat Genet. 2016 Jan;48(1):67-73. (PMID: 26642243) Annu Rev Pathol. 2008;3:189-220. (PMID: 18039144) Kidney Int. 2023 Jun;103(6):1105-1119. (PMID: 37097268) Sci Rep. 2015 Dec 09;5:18007. (PMID: 26648169) Nature. 2004 Aug 5;430(7000):694-9. (PMID: 15258597) Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L456-L469. (PMID: 30543305) Nat Immunol. 2019 Oct;20(10):1299-1310. (PMID: 31534238) Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1612-7. (PMID: 26802121) Public Health Genomics. 2022 Sep 12;:1-11. (PMID: 36096098) Eur J Immunol. 2011 Mar;41(3):595-601. (PMID: 21341261) Autoimmunity. 2014 Aug;47(5):307-19. (PMID: 24673262) Transplantation. 2003 Jan 15;75(1):3-9. (PMID: 12544863) J Allergy Clin Immunol. 2023 Jul;152(1):244-256.e4. (PMID: 36898482) Trends Immunol. 2020 May;41(5):421-435. (PMID: 32241683) Immunol Res. 2016 Apr;64(2):337-44. (PMID: 26135958) Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11115-20. (PMID: 25024217) Front Immunol. 2019 Feb 04;10:85. (PMID: 30778349) Nat Rev Nephrol. 2016 May;12(5):281-90. (PMID: 27026348) Nat Genet. 2008 Sep;40(9):1062-4. (PMID: 19165919) Exp Cell Res. 2022 Sep 1;418(1):113264. (PMID: 35714941) Dig Dis Sci. 2015 Oct;60(10):2976-84. (PMID: 25956706) World J Gastroenterol. 2012 Jul 21;18(27):3537-50. (PMID: 22826618) Ann Rheum Dis. 2018 May;77(5):728-735. (PMID: 29317407) FASEB J. 2022 Oct;36(10):e22527. (PMID: 36036542) Immunity. 2010 Aug 27;33(2):181-91. (PMID: 20705491) Int J Mol Sci. 2021 Apr 05;22(7):. (PMID: 33916456) Cell. 2009 May 15;137(4):721-35. (PMID: 19427028) Nat Rev Endocrinol. 2022 Sep;18(9):525-539. (PMID: 35668219) Science. 2000 Sep 29;289(5488):2350-4. (PMID: 11009421) Kidney Int. 2019 Feb;95(2):388-404. (PMID: 30551896) Clin Rheumatol. 2021 Jan;40(1):341-348. (PMID: 32488768) J Neuroimmunol. 2014 Jul 15;272(1-2):99-102. (PMID: 24852325) Nat Rev Dis Primers. 2020 Jan 23;6(1):7. (PMID: 31974366) J Clin Immunol. 2012 Dec;32(6):1287-91. (PMID: 22898832) Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):E9192-E9200. (PMID: 30209212) Trends Immunol. 2014 Jan;35(1):22-31. (PMID: 24246475) Nat Genet. 2011 Aug 14;43(9):908-12. (PMID: 21841782) Biochem Genet. 2018 Oct;56(5):478-488. (PMID: 29589214) Arthritis Res Ther. 2020 Sep 21;22(1):220. (PMID: 32958016) Transplant Proc. 2006 Sep;38(7):2164-7. (PMID: 16980032) Transplant Proc. 2006 Sep;38(7):2172-5. (PMID: 16980034) J Clin Med. 2023 Jun 19;12(12):. (PMID: 37373823) Mol Med Rep. 2017 Aug;16(2):1486-1492. (PMID: 29067462) Trends Immunol. 2009 Aug;30(8):383-91. (PMID: 19643665) Immunity. 2011 Jul 22;35(1):82-96. (PMID: 21723156) Nat Rev Immunol. 2012 Nov;12(11):774-85. (PMID: 23059429) Nat Immunol. 2011 Oct 23;12(12):1184-93. (PMID: 22019834) Nat Immunol. 2020 Apr;21(4):381-387. (PMID: 32205881) Nat Rev Rheumatol. 2014 Aug;10(8):445. (PMID: 25023452) J Biol Chem. 2017 Apr 28;292(17):7163-7172. (PMID: 28283576) Cells. 2020 Feb 03;9(2):. (PMID: 32028675) J Mol Med (Berl). 2010 Apr;88(4):413-21. (PMID: 20049410) Immunol Invest. 2015;44(5):497-508. (PMID: 26107748) Nat Cell Biol. 2019 Jun;21(6):731-742. (PMID: 31086261) Front Immunol. 2015 Nov 30;6:610. (PMID: 26648939) Transplant Direct. 2023 Jan 12;9(2):e1433. (PMID: 36700066) Transplantation. 2016 Nov;100(11):e106-e116. (PMID: 27495763) Clin Kidney J. 2022 May 11;15(11):2027-2038. (PMID: 36325013) Int J Immunogenet. 2015 Apr;42(2):106-10. (PMID: 25684197) Nat Rev Immunol. 2017 Sep;17(9):545-558. (PMID: 28580957) Immunol Lett. 2018 Jun;198:44-51. (PMID: 29608924) J Biol Chem. 1996 Jul 26;271(30):18068-73. (PMID: 8663499) Lancet. 2018 Nov 10;392(10159):2052-2090. (PMID: 30340847) |
| فهرسة مساهمة: | Keywords: A20; TNFAIP3; autoimmunity; kidney transplantation |
| المشرفين على المادة: | EC 3.4.19.12 (Tumor Necrosis Factor alpha-Induced Protein 3) EC 3.4.19.12 (TNFAIP3 protein, human) |
| تواريخ الأحداث: | Date Created: 20240627 Date Completed: 20240627 Latest Revision: 20240629 |
| رمز التحديث: | 20240629 |
| مُعرف محوري في PubMed: | PMC11203976 |
| DOI: | 10.3390/ijms25126628 |
| PMID: | 38928333 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1422-0067 |
|---|---|
| DOI: | 10.3390/ijms25126628 |